bms204352 has been researched along with ultram in 1 studies
| Studies (bms204352) | Trials (bms204352) | Recent Studies (post-2010) (bms204352) | Studies (ultram) | Trials (ultram) | Recent Studies (post-2010) (ultram) |
|---|---|---|---|---|---|
| 49 | 1 | 12 | 29 | 0 | 6 |
| Protein | Taxonomy | bms204352 (IC50) | ultram (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.3255 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 2.055 | |
| Mu-type opioid receptor | Homo sapiens (human) | 7.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 other study(ies) available for bms204352 and ultram
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |